Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1345-1353

  Benedetti, Sara ^a   Dimeco, Francesco ^b   Pollo, Bianca ^b   Cirenei, Nicola ^a   Colombo, Bruno M ^f   Bruzzone, Maria Grazia ^b   Cattaneo, Elena ^d   Vescovi, Angelo ^c   Didonato, Stefano ^a   Colombo, Mario P ^e   Finocchiaro, Gaetano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b Department of Neurosurgery ^*  (Italy)

^c Laboratory of Cellular Pathology   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; INTERLEUKIN 4; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER INHIBITION; CANCER TRANSPLANTATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; IMMUNOCOMPETENCE; IMMUNOGENETICS; MOUSE; NONHUMAN; NUDE MOUSE; RAT; RETROVIRUS;

ANIMALIA; HERPES; MUS MUSCULUS; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 16944361879     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1345     Document Type: Article

References (35)

1. BARBA, D., HARDIN, J., JASODHARA, R., and GAGE, R.H. (1993). Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79, 729-735.
2. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
3. BARNA, B.P., ESTES, M.L., PETTAY, J., IWASAKI, K., ZHOU, P., and BARNETT, G.H. (1995). Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J. Neuroimmunol. 60, 75-81.
4. BYRNES, A.P., RUSBY, J.E., WOOD, M.J.A., and CHARLTON, H.M. (1995). Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66, 1015-1024.
5. CATTANEO, E., MAGRASSI, L., BUTTI, G., SANTI, L., GIAVAZZI, A., and PEZZOTTA, S. (1994). A short-term analysis of the behaviour of conditionally immortalized neuronal progenitors and primary neuroepithelial cells implanted into the fetal rat brain. Devel. Brain. Res. 83, 197-208.
6. CHEN, S-H., CHEN, X.H.L., WANG, Y., KOSAI, K-I, FINEGOLD, M.J., RICH, S.S., and WOO, S.L.C. (1995). Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581.
7. COLOMBO, B.M., BENEDETTI, S., OTTOLENGHI, S., POLI, G., POLLO, B., MORA, M., and FINOCCHIARO, G. (1995). The "by-stander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772.
8. COOL, V., PIROTTE, B., GÉRARD, C., DARGENT J-L., BAUDSON, N., LEVIVIER, M., GOLDMAN, S., HILDEBRAND, J., BROTCHI, J., and VELU, T. (1996). Curative potential of Herpes Simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum. Gene Ther. 7, 627-635.
9. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
10. ELSHAMI, A.A., SAAVEDRA, A., ZHANG, H., KUCHARCZUCK, J.C., SPRAY, D.C., FISHMAN, G.I., AMIN, K.M., KAISER, L.R., and ABELDA, S.M. (1996). Gap junctions play a role in the "by-stander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 3, 85-92.
11. GAGE, F.H., RAY, J., and FISHER, L.J. (1995). Isolation, characterization and use of stem cells from the CNS. Annu. Rev. Neurosci. 18, 159-192.
12. GRITTI, A., PARATI, E.A., COVA, L., FROLICHSTHAL, P., GALLI, R., WANKE, E., FARAVELLI, L., MORASSUTTI, D.J., ROISEN, F., NICHOL, D.D., and VESCOVI, A.L. (1996). Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 16, 1091-1100.
13. HOWARD, M., FARRAR, J., HILFIKER, M., JOHNSON, B., TAKATSU, K., HAMAOKA, T., and PAUL, W.E. (1982). I dentification of a T cell-derived B cell growth factor distinct from interleukin-2. J. Exp. Med. 155, 914-923.
14. IZQUIERDO, M., CORTES, M., DE FELIPE, P., MARTIN, V., DIEZGUERRA, J., TALAVERA, A., and PEREZ-HIGUERAS, A. (1995). Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther. 2, 66-69.
15. KAWAKAMI, Y., ROSENBERG, S.A., and LOTZE, M.T. (1988). Interleukin-4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med. 168, 2183-2191.
16. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
17. MOSSMAN, T.R., BOND, M.W., COFFMAN, R.L., OHARA, J., and PAUL, W.E. (1986). T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83, 5654-5658.
18. NAGANO, N., SASAKI, H., AOYAGI, M., and HIRAKAWA, K. (1993). Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. 86, 117-125.
19. + lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J. Immunol. 153, 5659-5673.
20. PURI, R.K., LELAND, P., KREITMAN, R.J., and PASTAN, I. (1994). Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4-Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58, 574-581.
21. RAINOV, N.G., KRAMM, C.M., ABOODY-GUTERMAN, K., CHASE, M., UEKI, K., LOUIS, D.N., HARSHIV, G.R., CHIOCCA, E.A., and BREAKFIELD, X.O. (1996). Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Ther. 3, 99-106.
22. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
23. RAM, Z., WALBRIDGE, S., HEISS, J.D., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1994a). In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J. Neurosurg. 80, 535-540.
24. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1994b). The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg. 81, 256-260.
25. RAM, Z., CULVER, K., OSHIRO, E., VIOLA, J., DE VROOM, H., OTTO, E., LONG, Z., McGARRTTY, G., MUUL, G., KATZ, D., and BLAESE, R.M. (1995). Summary of results and conclusion of the gene therapy of malignant brain tumor: clinical study. J. Neurosurg. 82, 343A.
26. REYNOLDS, B.A., and WEISS, S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710.
27. ROSZMAN, T., ELLIOTT, L., and BROOKS, W. (1991). Modulation of T-cell function by gliomas. Immunol. Today 12, 370-374.
28. TAPSCOTT, S.J., MILLER, A.D., OLSON, J.M., BERGER, M.S., GROUDINE, M., and SPENCE, A.M. (1994). Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci USA 91, 8185-8189.
29. TEPPER, R.I. (1994). The eosinophil-mediated antitumor activity of interleukin-4. J Allergy Clin. Immunol. 94, 1225-1231.
30. TOPP, M.S., PAPADIMITRIOU, C.A., EITELBACH, F., KOENIGSMANN, M., OELMANN, E., KOEHLER, B., OBERBERG, D., REUFI, B., STEIN, H., THIEL, E., and BERDEL, W. (1995). Recombinant interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 55, 2173-2176.
31. VARELA-ECHEVARRIA, A., PROROCK, C.M., RON, Y., and DOUGHERTY, J.P. (1993). High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J. Virol. 67, 6357-6364.
32. VESCOVI, A.L., REYNOLDS, B.A., FRASER, D.D., and WEISS, S. (1993). bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11, 951-966.
33. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H., and HART, I.R. (1994). Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res. 54, 6228-6234.
34. WEI, M.X., TAMIYA, T., HURFORD, JR., R.K., BOVIATSIS, E.J., TEPPER, R.I., and CHIOCCA, E.A. (1995). Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum. Gene Ther. 6, 437-443.
35. YU, J.S., WEI, M.X., CHIOCCA, E.A., MARTUZA, R.L., and TEPPER, R.I. (1993). Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res. 53, 3125-3128.